Difference between revisions of "Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5 (Q9934)"
Jump to navigation
Jump to search
(Created claim: Issue (P104): 1, #quickstatements; #temporary_batch_1590000456415) |
(Created claim: DOI Identifier (P138): 10.1186/s12865-014-0064-x, #quickstatements; #temporary_batch_1590000649558) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1186/s12865-014-0064-x / rank | |||
| + | Normal rank | ||
Revision as of 19:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Deng Zhenling
0 references
Wu Yanhong
0 references
Ma Wenbo
0 references
1
0 references
